JP2016520656A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520656A5
JP2016520656A5 JP2016518385A JP2016518385A JP2016520656A5 JP 2016520656 A5 JP2016520656 A5 JP 2016520656A5 JP 2016518385 A JP2016518385 A JP 2016518385A JP 2016518385 A JP2016518385 A JP 2016518385A JP 2016520656 A5 JP2016520656 A5 JP 2016520656A5
Authority
JP
Japan
Prior art keywords
propylene glycol
glyceryl
glycol
pharmaceutical composition
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016518385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520656A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/040560 external-priority patent/WO2014197398A1/en
Publication of JP2016520656A publication Critical patent/JP2016520656A/ja
Publication of JP2016520656A5 publication Critical patent/JP2016520656A5/ja
Pending legal-status Critical Current

Links

JP2016518385A 2013-06-03 2014-06-02 コルチコステロイド組成物 Pending JP2016520656A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361830531P 2013-06-03 2013-06-03
US61/830,531 2013-06-03
PCT/US2014/040560 WO2014197398A1 (en) 2013-06-03 2014-06-02 Corticosteroid compositions

Publications (2)

Publication Number Publication Date
JP2016520656A JP2016520656A (ja) 2016-07-14
JP2016520656A5 true JP2016520656A5 (enExample) 2017-07-13

Family

ID=51014660

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016518385A Pending JP2016520656A (ja) 2013-06-03 2014-06-02 コルチコステロイド組成物

Country Status (9)

Country Link
EP (1) EP3003272A1 (enExample)
JP (1) JP2016520656A (enExample)
CN (1) CN105263474A (enExample)
AR (1) AR096459A1 (enExample)
AU (1) AU2014275195A1 (enExample)
CA (1) CA2912873A1 (enExample)
HK (1) HK1223300A1 (enExample)
MX (1) MX2015016603A (enExample)
WO (1) WO2014197398A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011026076A2 (en) 2009-08-31 2011-03-03 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
ITUB20153460A1 (it) 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche acquose contenenti esteri dell?acido pelargonico
MX391097B (es) * 2017-11-27 2025-03-21 Umecrine Cognition Ab FORMULACIÓN FARMACÉUTICA DE 3A-ETINIL-3ß-HIDROXIANDROSTAN-17-ONA OXIMA.
WO2023277616A1 (ko) * 2021-06-30 2023-01-05 주식회사 디네이쳐 중대가리풀 유래의 추출물을 포함하는 탈모기능성 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
JP3471840B2 (ja) * 1993-03-04 2003-12-02 日本ワイスレダリー株式会社 外用剤
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
GB9618964D0 (en) * 1996-09-11 1996-10-23 Tillotts Pharma Ag Oral composition
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
PT1194109E (pt) * 1999-06-25 2004-12-31 Durham Pharmaceuticals Ltd Formulacoes topicas compreendendo agentes de penetracao na pele e utilizacao dasmesmas
JP2001233772A (ja) * 2000-02-23 2001-08-28 Taiho Yakuhin Kogyo Kk 外用剤組成物
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
EP1648412B1 (en) * 2003-07-07 2007-11-14 Nares AB Microemulsions and its use for preventing airway diseases
PL1744760T3 (pl) * 2004-04-22 2015-04-30 Acucort Ab Kompozycja farmaceutyczna do ostrego leczenia glikokortykosteroidami
AU2005313601B2 (en) * 2004-12-09 2012-05-24 Bayer Intellectual Property Gmbh Stabilisation of glucocorticoid esters with acids
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
GB2445539A (en) * 2006-12-29 2008-07-16 Ardana Bioscience Ltd Bigel composition
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
RS53809B1 (sr) * 2010-06-11 2015-06-30 Leo Pharma A/S Farmaceutska kompozicija spreja za kožu koja sadrži analog vitamina d i kortikosteroid
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases
CN102940594A (zh) * 2012-12-04 2013-02-27 艾能赛克机械设备(江苏)有限公司 一种头发调理剂

Similar Documents

Publication Publication Date Title
JP2016520656A5 (enExample)
US20190000977A1 (en) Corticosteroid compositions
US20100210614A2 (en) Compositions and methods for enhancing corticosteroid delivery
RU2013128607A (ru) Фармацевтические составы, содержащие кортикостероиды, для топикального применения
JP2013542990A5 (enExample)
JP2010540671A5 (enExample)
KR101121529B1 (ko) 스테로이드의 경시적 안정성이 개선된 외용 제제
JP2011502172A5 (enExample)
JPH11130679A5 (enExample)
RU2015133465A (ru) Стабилизированные композиции, содержащие гиалуроновую кислоту
JP2016520656A (ja) コルチコステロイド組成物
US12076403B2 (en) Pharmaceutical formulations containing corticosteroids for topical administration
US20170246184A1 (en) Methods of treating testosterone deficiency
JP2006518382A5 (enExample)
RU2005129276A (ru) Применение стероидов для лечения субъектов, страдающих заболеванием глаз
Baeck et al. C16‐methyl corticosteroids are far less allergenic than the non‐methylated molecules
JP2004519451A5 (enExample)
US20180078492A1 (en) Compositions And Method For Treating Fungal Skin Conditions And Inflammation
JP2016065006A5 (enExample)
AU2002360589B9 (en) Compositions and methods for enhancing corticosteriod delivery
Hafner et al. Allergic contact dermatitis to corticosteroids: experience of a referral clinic from 2014 to 2018
US20080171729A1 (en) Use Of A Steroid For Enhancement Of Skin Permeability
CN104146950A (zh) 一种复方酮康唑软膏及其制备方法
BR112023005158A2 (pt) Suspensões aquosas sem peg para administração parenteral de um corticosteroide
JP2015205877A (ja) 抗真菌剤とステロイド系薬剤とを含有する外用医薬組成物